CAR-T Therapy Trials: Unique Regulatory Considerations
CAR-T Therapy Trials: Unique Regulatory Considerations Regulatory Considerations in CAR-T Therapy Clinical Trials Introduction to CAR-T Therapy Trials Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized treatment for certain hematologic malignancies, offering durable remissions even in heavily pretreated patients. These personalized cell-based therapies involve collecting a patient’s T cells, genetically engineering them to target specific…
Read More “CAR-T Therapy Trials: Unique Regulatory Considerations” »